Cargando…

Mortality in cold agglutinin disease shows seasonal pattern

Detalles Bibliográficos
Autores principales:	Hansen, Dennis Lund, Möller, Sören, Berentsen, Sigbjørn, Frederiksen, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541684/ https://www.ncbi.nlm.nih.gov/pubmed/35531960 http://dx.doi.org/10.1111/trf.16894

Ejemplares similares

Sutimlimab for the Treatment of Cold Agglutinin Disease
por: Berentsen, Sigbjørn
Publicado: (2023)

New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
por: Berentsen, Sigbjørn
Publicado: (2020)

Cold agglutinin disease: current challenges and future prospects
por: Berentsen, Sigbjørn, et al.
Publicado: (2019)

Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapy
por: Berentsen, Sigbjørn, et al.
Publicado: (2007)

Development of Multiple Myeloma of the IgA Type in a Patient with Cold Agglutinin Disease: Transformation or Coincidence?
por: Sefland, Øystein, et al.
Publicado: (2019)

Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results
por: Röth, Alexander, et al.
Publicado: (2022)

Cold Agglutinin Disease
por: Gabbard, Amy P., et al.
Publicado: (2020)

Acute exacerbation of cold agglutinin disease during operation
por: Jeong, Jinyoung, et al.
Publicado: (2013)

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial
por: Röth, Alexander, et al.
Publicado: (2022)

Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow‐up
por: Hansen, Dennis Lund, et al.
Publicado: (2022)

Necrosis secondary to cold agglutinin disease
por: Nakagawa, Hiroaki, et al.
Publicado: (2022)

Pembrolizumab-Induced Cold Agglutinin Disease
por: Atiq, Osman, et al.
Publicado: (2020)

Cold Agglutinin Disease with Erythrophagocytosis by Neutrophils Occurring During Recovery Phase of Chickenpox
por: Walia, Harpreet, et al.
Publicado: (2013)

Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease
por: Gelbenegger, Georg, et al.
Publicado: (2022)

Tozinameran: Cold agglutinin disease: case report
Publicado: (2022)

Cold Agglutinin Disease; A Laboratory Challenge
por: Nikousefat, Zahra, et al.
Publicado: (2015)

SARS-CoV-2-associated cold agglutinin disease: a report of two cases
por: Huscenot, Tessa, et al.
Publicado: (2020)

Perioperative management of a patient with severe cold agglutinin disease by using multimodal warming measures
por: Koyama, Yukihide, et al.
Publicado: (2021)

Eliminating or Minimizing the Effects of Cold Agglutinins on the Accuracy of Complete Blood Count Results
por: La Gioia, Antonio
Publicado: (2019)

A COLD CASE OF COVID-19-INDUCED COLD AGGLUTININ DISEASE
por: DOUEN, AARON, et al.
Publicado: (2021)

Cold agglutinin disease in sepsis: A rare entity
por: Garg, Ravinder, et al.
Publicado: (2015)

Increasing Incidence and Prevalence of Acquired Hemolytic Anemias in Denmark, 1980–2016
por: Hansen, Dennis Lund, et al.
Publicado: (2020)

P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY
por: Röth, Alexander, et al.
Publicado: (2023)

COVID-19 and Cold Agglutinin Hemolytic Anemia
por: Maslov, Diana V., et al.
Publicado: (2020)

Early Mortality in Paroxysmal Nocturnal Hemoglobinuria
por: Sørensen, Anne Lykke, et al.
Publicado: (2023)

PB2549: CO-EXISTENT COLD AGGLUTININ DISEASE AND CRYOGLOBULINAEMIA
por: Japzon, Nicole, et al.
Publicado: (2023)

Correspondence: Response to “Eliminating or Minimizing the Effects of Cold Agglutinins on the Accuracy of Complete Blood Count Results”
por: Rim, John Hoon, et al.
Publicado: (2019)

Cold Agglutinins and Cryoglobulins Associate With Clinical and Laboratory Parameters of Cold Urticaria
por: Bizjak, Mojca, et al.
Publicado: (2021)

P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY
por: Röth, Alexander, et al.
Publicado: (2023)

P1539: SEASONALITY OF HEALTHCARE RESOURCE UTILIZATION AMONG COLD AGGLUTININ DISEASE AMONG PATIENTS IN DENMARK: A RETROSPECTIVE ANALYSIS
por: Fryzek, J., et al.
Publicado: (2022)

Transient Cold Agglutinins in a Patient With COVID-19
por: Kaur, Jasmeet, et al.
Publicado: (2021)

Two Cases of Primary Cold Agglutinin Disease Associated with Megaloblastic Anemia
por: Imashuku, Shinsaku, et al.
Publicado: (2015)

Glucocorticoid-Responsive Cold Agglutinin Disease in a Patient with Rheumatoid Arthritis
por: Honne, Kyoko, et al.
Publicado: (2015)

Cryoballoon Ablation Induced Hyperkalemia due to Possible Cold Agglutinin Disease
por: Kumanomido, Jun, et al.
Publicado: (2019)

Cold agglutinin disease and COVID-19 requiring therapeutic plasma exchange
por: Ahmed, Yousuf, et al.
Publicado: (2021)

Neutrophilic erythrophagocytosis in myelodysplastic syndrome and cold agglutinin disease co‐occurrence
por: Amelirad, Asra, et al.
Publicado: (2023)

Cold agglutinin disease: A case report with atypical clinical findings
por: Balaja, Warren, et al.
Publicado: (2023)

Effects of Cold Agglutinin on the Accuracy of Complete Blood Count Results and Optimal Sample Pretreatment Protocols for Eliminating Such Effects
por: Rim, John Hoon, et al.
Publicado: (2018)

Role of Complement in Autoimmune Hemolytic Anemia
por: Berentsen, Sigbjørn
Publicado: (2015)

Bilateral retinal vasculitis associated with cold agglutinin disease treated with obinutuzumab and infliximab
por: Than, Ngoc Trong Tuong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9tnoac2kqi5d185mms0bjo39kq